Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
After finishing at $1.43 in the prior trading day, Mainz Biomed N.V (NASDAQ: MYNZ) closed at $1.44, up 0.70%. In other words, the price has increased by $0.70 from its previous closing price. On the day, 0.99 million shares were traded.
Ratios:
Our goal is to gain a better understanding of MYNZ by taking a closer look at its different ratios.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on February 14, 2025, initiated with a Buy rating and assigned the stock a target price of $14.
Stock Price History:
Over the past 52 weeks, MYNZ has reached a high of $22.40, while it has fallen to a 52-week low of $1.37. The 50-Day Moving Average of the stock is -39.96%, while the 200-Day Moving Average is calculated to be -76.22%.
Shares Statistics:
A total of 3.81M shares are outstanding, with a floating share count of 3.69M. Insiders hold about 3.35% of the company’s shares, while institutions hold 6.13% stake in the company.
